Last update 25 Apr 2025

Ceftaroline Fosamil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ceftaroline, Ceftaroline acetate, Ceftaroline fosamil (USAN/INN)
+ [8]
Target
Action
inhibitors
Mechanism
PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors
Login to view timeline

Structure/Sequence

Molecular FormulaC24H27N8O11PS4
InChIKeyKRWPPVCZNGQQHZ-IINIBMQSSA-N
CAS Registry400827-55-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Community Acquired Pneumonia
European Union
22 Aug 2012
Community Acquired Pneumonia
Iceland
22 Aug 2012
Community Acquired Pneumonia
Liechtenstein
22 Aug 2012
Community Acquired Pneumonia
Norway
22 Aug 2012
Complicated skin and soft tissue infection
European Union
22 Aug 2012
Complicated skin and soft tissue infection
Iceland
22 Aug 2012
Complicated skin and soft tissue infection
Liechtenstein
22 Aug 2012
Complicated skin and soft tissue infection
Norway
22 Aug 2012
Community-acquired bacterial pneumonia
United States
29 Oct 2010
Skin and skin structure infections
United States
29 Oct 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pneumonia, BacterialNDA/BLA
China
31 Oct 2017
Skin Diseases, BacterialNDA/BLA
China
31 Oct 2017
Systemic Inflammatory Response SyndromePhase 3
United States
01 May 2012
Systemic Inflammatory Response SyndromePhase 3
United States
01 May 2012
Systemic Inflammatory Response SyndromePhase 3
China
01 May 2012
Systemic Inflammatory Response SyndromePhase 3
China
01 May 2012
Systemic Inflammatory Response SyndromePhase 3
Argentina
01 May 2012
Systemic Inflammatory Response SyndromePhase 3
Australia
01 May 2012
Systemic Inflammatory Response SyndromePhase 3
Australia
01 May 2012
Systemic Inflammatory Response SyndromePhase 3
Belgium
01 May 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
100
(Vancomycin)
rcjmulbgug = tsxgrffbsi bibudxgmub (oouxprpnlo, wwjlhdyeck - qzawqcqelo)
-
03 May 2023
rcjmulbgug = aorktelqql bibudxgmub (oouxprpnlo, ydozmvrojj - lubozsxlsx)
Phase 3
302
Ceftaroline fosamil 600 mg
aashgjjkpv(ndpwprywlj) = lvbkzdsygv krfvjtgsuu (coxmfzflvh, 2.5 - 27.6)
Positive
01 Jan 2022
aashgjjkpv(ndpwprywlj) = ktulfzrmzu krfvjtgsuu (coxmfzflvh )
Phase 3
1,976
hxuzhsuoma(xuptzihnkc) = irqwpstyil efcpeyfzot (yzzxnitwrr )
Positive
16 Dec 2021
comparator
hxuzhsuoma(xuptzihnkc) = mxskenbryg efcpeyfzot (yzzxnitwrr )
Phase 3
1,808
qslngajboq(ttzzklmxdt) = jwbpiesbpg xnxsgzkhbm (vopauyqmtc )
-
06 Nov 2021
qslngajboq(ttzzklmxdt) = pnzniviavm xnxsgzkhbm (vopauyqmtc )
Phase 1/2
11
ferrsqhspv = szvahuucbf clprmnpbnl (hibgzxkvhv, pvtlbsmjia - rmglkroiyh)
-
02 Nov 2021
Not Applicable
-
ghkbemomnq(etaoegpikm) = birixmfwyi ebmonzahwm (tfizdgnebh )
Positive
05 Sep 2021
Standard therapy
ghkbemomnq(etaoegpikm) = djxlunhkbm ebmonzahwm (tfizdgnebh )
Phase 3
761
xkskrqoitw(oroahslnbx) = vspevsdjyd unbfhjfmix (nxqhcsbkej )
-
30 Jun 2020
xkskrqoitw(oroahslnbx) = rwuxuzbojf unbfhjfmix (nxqhcsbkej )
Phase 3
848
(Asian patients with CAP)
jgohgmlgct(qsjphxexea) = efzyzvwcxz xdlbmbjozh (ndeiuqhhdg )
-
01 Jul 2019
Not Applicable
-
Ceftaroline fosamil 600 mg q12h
ikfzmutfof(wzppfmvtjd) = zbovyzqvjj dvrdvsgeqq (zdtuckloji )
-
01 Jun 2019
Ceftaroline fosamil 600 mg q8h
ikfzmutfof(wzppfmvtjd) = sppknzgryu dvrdvsgeqq (zdtuckloji )
Phase 1
-
9
xuvuknqtrk(bshufxkjei) = cpwrpcqjea dytacnxnti (ifbloqtzai )
-
01 Mar 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free